{
    "id": "bowtie_digoxin_standard_v2026_20",
    "type": "bowtie",
    "stem": "An 81-year-old client with congestive heart failure (CHF) reports seeing 'blurred greenish-yellow halos' around the television. Based on the documentation in the Cardiology Treatment & Antidote Inventory tab, complete the bowtie by selecting the most likely condition, the two actions the nurse should take, and the two parameters the nurse should monitor.",
    "itemContext": {
        "tabs": [
            {
                "id": "sbar",
                "title": "SBAR",
                "content": "<b>Situation:</b> Visual and GI side effects on cardiac medication. <br><b>Background:</b> Taking Digoxin 0.25mg daily for AFib/CHF. Complaining of no appetite and 'flickering' lights. <br><b>Assessment:</b> Pulse is irregular at 48 bpm. <br><b>Recommendation:</b> Immediate serum level check and heart rhythm monitor."
            },
            {
                "id": "labs",
                "title": "Cardiology Labs & Inventory",
                "content": "<table><thead><tr><th>Test</th><th>Finding</th><th>Interpretation</th></tr></thead><tbody><tr><td>Serum Digoxin</td><td>3.1 ng/mL</td><td>Critical High (Normal 0.5-2.0)</td></tr><tr><td>Serum Potassium</td><td>4.8 mEq/L</td><td>High-Normal</td></tr><tr><td>Creatinine</td><td>2.1 mg/dL</td><td>Decreased clearance (Normal < 1.3)</td></tr><tr><td>Antidote Stock</td><td>Digoxin Immune Fab (DigiFab)</td><td>Available in pharmacy</td></tr></tbody></table>"
            },
            {
                "id": "ekg",
                "title": "Heart Rhythm Monitor",
                "content": "Sinus Bradycardia with frequent premature ventricular contractions (PVCs)."
            }
        ]
    },
    "bowtieData": {
        "conditionOptions": [
            {
                "id": "c1",
                "text": "Hypoglycemic Vision Loss"
            },
            {
                "id": "c2",
                "text": "Acute Digoxin Toxicity"
            },
            {
                "id": "c3",
                "text": "Expected Atrial Fibrillation Control"
            }
        ],
        "actionOptions": [
            {
                "id": "a1",
                "text": "Withhold the scheduled dose of Digoxin"
            },
            {
                "id": "a2",
                "text": "Administer Digoxin Immune Fab (DigiFab) as prescribed"
            },
            {
                "id": "a3",
                "text": "Place the client in a prone position to improve cardiac output"
            },
            {
                "id": "a4",
                "text": "Increase Potassium intake to 8.0 mEq/L to displace the drug"
            }
        ],
        "parameterOptions": [
            {
                "id": "p1",
                "text": "Continuous cardiac monitoring (Checking for heart block/PVCs)"
            },
            {
                "id": "p2",
                "text": "Serum Digoxin levels and Electrolytes"
            },
            {
                "id": "p3",
                "text": "Presence of a positive Kernig's sign"
            },
            {
                "id": "p4",
                "text": "Daily measurement of pupillary reactivity"
            }
        ]
    },
    "correctAnswers": {
        "condition": "c2",
        "actions": [
            "a1",
            "a2"
        ],
        "parameters": [
            "p1",
            "p2"
        ]
    },
    "pedagogy": {
        "bloomLevel": "analyze",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 3,
        "topicTags": [
            "Digoxin",
            "Antidotes",
            "Cardiac Medications"
        ]
    },
    "rationale": {
        "correct": "This client has objective evidence of Acute Digoxin Toxicity (c2): Serum level 3.1 (critical), visual halos, Bradycardia (HR 48), and PVCs. The primary cause is likely renal failure (Creatinine 2.1) reducing drug clearance. Priority actions are to hold the drug (a1) and administer the antidote, DigiFab (a2). Parameter monitoring focuses on the heart rhythm (p1) (the most dangerous part of toxicity) and drug levels (p2).",
        "clinicalPearls": [
            "If the apical pulse is < 60 in an adult, ALWAYS hold digoxin and verify.",
            "Early signs of toxicity are often GI (Nausea/Anorexia) rather than visual.",
            "Digoxin is primarily cleared by the kidneys; elderly patients with low GFR are at high risk."
        ],
        "questionTrap": {
            "trap": "Asking the patient if they need new glasses for their 'halos'.",
            "howToOvercome": "Green/Yellow halos or 'flickering' lights in a heart patient is almost always Digoxin toxicity. It is a neurological/cardiac emergency, not an optometry one."
        },
        "mnemonic": {
            "title": "DIG-FAST",
            "expansion": "D-Decreased Pulse. I-Images (Halos). G-Gut (N/V). F-Feeling low (Malaise). A-Arrhythmias. S-Slow HR. T-Toxic (> 2.0)."
        }
    },
    "scoring": {
        "method": "polytomous",
        "maxPoints": 5
    },
    "sentinelStatus": "healed_v2026_v9"
}